Literature DB >> 15320894

Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

J Dormans1, M Burger, D Aguilar, R Hernandez-Pando, K Kremer, P Roholl, S M Arend, D van Soolingen.   

Abstract

One of the most intriguing aspects of tuberculosis is that the outcome of an infection with M. tuberculosis (TB) is highly variable between individuals. The possibility of differences in virulence between M. tuberculosis strains or genotypes has only recently been studied. There is evidence of multifactorial genetic predisposition in humans that influences the susceptibility to tuberculosis. A better understanding of differences in virulence between M. tuberculosis genotypes could be important with regard to the efforts at TB control and the development of improved antituberculosis vaccines. Survival, lung pathology, bacterial load and delayed type hypersensitivity (DTH) responses of BALB/c mice after intratracheal infection with any of 19 different M. tuberculosis complex strains of 11 major genotype families were studied. The results indicate that among genetically different M. tuberculosis strains a very broad response was present with respect to virulence, pathology, bacterial load and DTH. 'Low'-responders were the H37Rv, Canetti, Beijing-1 strains, while Beijing-2,3, Africa-2 and Somalia-2 strains were 'high'-responders. A severe pathological response correlates with a high mortality and a high CFU counts in lungs, but poorly with the degree of the DTH response.

Entities:  

Mesh:

Year:  2004        PMID: 15320894      PMCID: PMC1809137          DOI: 10.1111/j.1365-2249.2004.02551.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens.

Authors:  R Bellamy
Journal:  Microbes Infect       Date:  1999-01       Impact factor: 2.700

2.  Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis.

Authors:  R Hernandez-Pando; T Schön; E H Orozco; J Serafin; I Estrada-García
Journal:  Exp Toxicol Pathol       Date:  2001-09

3.  Variants of the human NRAMP1 gene and susceptibility to tuberculosis in Morocco.

Authors:  J El Baghdadi; N Remus; A Benslimane; H El Annaz; M Chentoufi; L Abel; E Schurr
Journal:  Int J Tuberc Lung Dis       Date:  2003-06       Impact factor: 2.373

4.  Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110.

Authors:  Jeremy W Dale; Hasan Al-Ghusein; Salim Al-Hashmi; Philip Butcher; Anne L Dickens; Francis Drobniewski; Ken J Forbes; Stephen H Gillespie; Dianie Lamprecht; Timothy D McHugh; Richard Pitman; Nalin Rastogi; Andrew T Smith; Christophe Sola; Hasan Yesilkaya
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

5.  Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease.

Authors:  A Wangoo; T Sparer; I N Brown; V A Snewin; R Janssen; J Thole; H T Cook; R J Shaw; D B Young
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis.

Authors:  G T Seah; G M Scott; G A Rook
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

Review 8.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

9.  A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes.

Authors:  B López; D Aguilar; H Orozco; M Burger; C Espitia; V Ritacco; L Barrera; K Kremer; R Hernandez-Pando; K Huygen; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

10.  Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review.

Authors:  Judith R Glynn; Jennifer Whiteley; Pablo J Bifani; Kristin Kremer; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more
  80 in total

1.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity.

Authors:  Ernestas Janulionis; Carolina Sofer; Stephan K Schwander; Denarra Nevels; Barry Kreiswirth; Elena Shashkina; Robert S Wallis
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Epidemiologic consequences of microvariation in Mycobacterium tuberculosis.

Authors:  Barun Mathema; Natalia Kurepina; Guibin Yang; Elena Shashkina; Claudia Manca; Carolina Mehaffy; Helle Bielefeldt-Ohmann; Shama Ahuja; Dorothy A Fallows; Angelo Izzo; Pablo Bifani; Karen Dobos; Gilla Kaplan; Barry N Kreiswirth
Journal:  J Infect Dis       Date:  2012-02-07       Impact factor: 5.226

4.  Assessment of mycobacterial interspersed repetitive unit-QUB markers to further discriminate the Beijing genotype in a population-based study of the genetic diversity of Mycobacterium tuberculosis clinical isolates from Okinawa, Ryukyu Islands, Japan.

Authors:  Julie Millet; Chika Miyagi-Shiohira; Nobuhisa Yamane; Christophe Sola; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2007-09-26       Impact factor: 5.948

Review 5.  Heterogeneity in tuberculosis.

Authors:  Anthony M Cadena; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Rev Immunol       Date:  2017-07-24       Impact factor: 53.106

6.  Investigating the Pathogen Genomic Determinants of Tuberculosis Transmission.

Authors:  Louis Grandjean
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

7.  Parallel in vivo experimental evolution reveals that increased stress resistance was key for the emergence of persistent tuberculosis bacilli.

Authors:  Aideen C Allen; Wladimir Malaga; Cyril Gaudin; Arnaud Volle; Flavie Moreau; Ali Hassan; Catherine Astarie-Dequeker; Antonio Peixoto; Rudy Antoine; Alexandre Pawlik; Wafa Frigui; Céline Berrone; Roland Brosch; Philip Supply; Christophe Guilhot
Journal:  Nat Microbiol       Date:  2021-07-22       Impact factor: 17.745

8.  pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence.

Authors:  Eva C Boritsch; Wafa Frigui; Alessandro Cascioferro; Wladimir Malaga; Gilles Etienne; Françoise Laval; Alexandre Pawlik; Fabien Le Chevalier; Mickael Orgeur; Laurence Ma; Christiane Bouchier; Timothy P Stinear; Philip Supply; Laleh Majlessi; Mamadou Daffé; Christophe Guilhot; Roland Brosch
Journal:  Nat Microbiol       Date:  2016-01-27       Impact factor: 17.745

9.  Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis.

Authors:  Guy Thwaites; Maxine Caws; Tran Thi Hong Chau; Anthony D'Sa; Nguyen Thi Ngoc Lan; Mai Nguyet Thu Huyen; Sebastien Gagneux; Phan Thi Hoang Anh; Dau Quang Tho; Estee Torok; Nguyen Thi Quynh Nhu; Nguyen Thi Hong Duyen; Phan Minh Duy; Jonathan Richenberg; Cameron Simmons; Tran Tinh Hien; Jeremy Farrar
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

10.  Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis.

Authors:  William J Burman; Erin E Bliven; Lauren Cowan; Lorna Bozeman; Payam Nahid; Lois Diem; Andrew Vernon
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.